Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about Ocular-2023-12-15
$115.1 Million
Image
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Keros-2024-01-03
$161.0 Million
Image
Keros Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about CatalystPharmaceuticals-2024-01-04
$150.0 Million
Image
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Praxis-20234-01-11
$172.4 Million
Image
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Merit Medical Systems, Inc.
$747.5 Million
Image
Merit Medical Systems, Inc.
Convertible Offering
Active Bookrunner
Read more
about CCC-2023-11-08
$733.6 Million
Image
CCC Intelligent Solutions Holdings Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Skyward-2023-11-15
$175.3 Million
Image
Skyward Specialty Insurance
Follow-On Offering
Active Bookrunner
Read more
about ScholarRock-2023-10-13
Image
Scholar Rock Holding Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Nuvalent-2023-10-17
$300.0 Million
Image
Nuvalent, Inc.
Follow-On Offering
Active Bookrunner
Read more
about MadrigalPharmaceuticals-2023-09-28
$499.9 Million
Image
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 3
Next page
››
Subscribe to Active Bookrunner